Liver X receptor activation promotes macrophage-to-feces reverse cholesterol transport in a dyslipidemic hamster model

被引:33
作者
Briand, Francois [1 ]
Treguier, Morgan [2 ]
Andre, Agnes [1 ,2 ]
Grillot, Didier [3 ]
Issandou, Marc [3 ]
Ouguerram, Khadija [2 ]
Sulpice, Thierry [1 ]
机构
[1] Prologue Biotech, Physiogenex SAS, F-31682 Labege, France
[2] CHU Nantes, Ctr Rech Nutr Humaine, INSERM, U915,Hotel Dieu, F-44000 Nantes, France
[3] GlaxoSmith Kline, Les Ulis Res Ctr, F-91951 Les Ulis, France
关键词
cholesteryl ester transfer protein; lipoprotein; dyslipidemia; atherosclerosis; INSULIN-RESISTANCE; HEPATIC STEATOSIS; LIPID-METABOLISM; LXR AGONISTS; ANIMAL-MODEL; IN-VIVO; MICE; EXCRETION; INTESTINE; ALPHA;
D O I
10.1194/jlr.M001552
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Liver X receptor (LXR) activation promotes reverse cholesterol transport (RCT) in rodents but has major side effects (increased triglycerides and LDL-cholesterol levels) in species expressing cholesteryl ester transfer protein (CETP). In the face of dyslipidemia, it remains unclear whether LXR activation stimulates RCT in CETP species. We therefore used a hamster model made dyslipidemic with a 0.3% cholesterol diet and treated with vehicle or LXR agonist GW3965 (30 mg/kg bid) over 10 days. To investigate RCT, radiolabeled H-3-cholesterol macrophages or H-3-cholesteryl oleate-HDL were then injected to measure plasma and feces radioactivity over 72 or 48 h, respectively. The cholesterol-enriched diet increased VLDL-triglycerides and total cholesterol levels in all lipoprotein fractions and strongly increased liver lipids. Overall, GW3965 failed to improve both dyslipidemia and liver steatosis. However, after H-3-cholesterol labeled macrophage injection, GW3965 treatment significantly increased the H-3-tracer appearance by 30% in plasma over 72 h, while fecal H-3-cholesterol excretion increased by 156% (P < 0.001). After H-3-cholesteryl oleate-HDL injection, GW3965 increased HDL-derived cholesterol fecal excretion by 64% (P < 0.01 vs. vehicle), while plasma fractional catabolic rate remained unchanged. Despite no beneficial effect on dyslipidemia, LXR activation promotes macrophage-to-feces RCT in dyslipidemic hamsters. These results emphasize the use of species with a more human-like lipoprotein metabolism for drug profiling.-Briand, F., M. Treguier, A. Andre, D. Grillot, M. Issandou, K. Ouguerram, and T. Sulpice. Liver X receptor activation promotes macrophage-to-feces reverse cholesterol transport in a dyslipidemic hamster model. J. Lipid Res. 2010. 51: 763-770.
引用
收藏
页码:763 / 770
页数:8
相关论文
共 36 条
[31]   LXR-induced redistribution of ABCG1 to plasma membrane in macrophages enhances cholesterol mass efflux to HDL [J].
Wang, Nan ;
Ranalletta, Mollie ;
Matsuura, Fumihiko ;
Peng, Felix ;
Tall, Alan R. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (06) :1310-1316
[32]   High fat fed hamster, a unique animal model for treatment of diabetic dyslipidemia with peroxisome proliferator activated receptor alpha selective agonists [J].
Wang, PR ;
Qiu, G ;
Ippolito, M ;
Wu, M ;
Milot, D ;
Ventre, J ;
Doebber, T ;
Wright, SD ;
Chao, YS .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 427 (03) :285-293
[33]   Kinetic parameters for high density lipoprotein apoprotein AI and cholesteryl ester transport in the hamster [J].
Woollett, LA ;
Spady, DK .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (07) :1704-1713
[34]   Indazole-Based Liver X Receptor (LXR) Modulators with Maintained Atherosclerotic Lesion Reduction Activity but Diminished Stimulation of Hepatic Triglyceride Synthesis [J].
Wrobel, Jay ;
Steffan, Robert ;
Bowen, S. Marc ;
Magolda, Ronald ;
Matelan, Edward ;
Unwalla, Rayomand ;
Basso, Michael ;
Clerin, Valerie ;
Gardell, Stephen J. ;
Nambi, Ponnal ;
Quinet, Elaine ;
Reminick, Jason I. ;
Vlasuk, George P. ;
Wang, Shuguang ;
Feingold, Irene ;
Huselton, Christine ;
Bonn, Tomas ;
Farnegardh, Mathias ;
Hansson, Tomas ;
Nilsson, Annika Goos ;
Wilhelmsson, Anna ;
Zamaratski, Edouard ;
Evans, Mark J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (22) :7161-7168
[35]   Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8 [J].
Yu, LQ ;
York, J ;
von Bergmann, K ;
Lutjohann, D ;
Cohen, JC ;
Hobbs, HH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (18) :15565-15570
[36]   LXR Regulates Cholesterol Uptake Through Idol-Dependent Ubiquitination of the LDL Receptor [J].
Zelcer, Noam ;
Hong, Cynthia ;
Boyadjian, Rima ;
Tontonoz, Peter .
SCIENCE, 2009, 325 (5936) :100-104